HMS
CHRS icon

Hanseatic Management Services’s Coherus Oncology CHRS Stock Holding History

Hanseatic Management Services’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-189
Closed -$3K – 271
2018
Q3 		$3K Hold
189
– – ﹤0.01% 296
2018
Q2 		$3K Buy
+189
New +$2.71K ﹤0.01% 279

Other funds holding CHRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hanseatic Management Services's CHRS Position: Q4 2018 in Review

Hanseatic Management Services sold out of Coherus Oncology (CHRS) in Q4 2018, closing a stake of 189 shares — an estimated $3K sold.

Hanseatic Management Services first reported a position in CHRS in Q2 2018 and held it in 2 quarters. The position peaked at $3K in Q3 2018. 111 funds tracked by Wall St. Rank hold CHRS as of Q4 2018.

  • Hanseatic Management Services reported no remaining Coherus Oncology position as of Q4 2018 after selling out during the quarter.
  • Hanseatic Management Services sold 189 Coherus Oncology shares in Q4 2018, an estimated $3K.
  • Hanseatic Management Services first reported a position in Coherus Oncology in Q2 2018 and held it in 2 quarters.
  • Hanseatic Management Services's Coherus Oncology position peaked at $3K in Q3 2018.
  • 111 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2018.

Based on Hanseatic Management Services's 13F filing for Q4 2018, filed 29 Jan 2019.